In memoriam 'analgesic nephropathy' (circa 1972-2006)

Nephrology Dialysis Transplantation

Volumn 22, Issue 4, 2007, Pages 999-1001

  Michielsen, Paul ^a  

^a NONE   (Belgium)

Author keywords

Analgesic nephropathy; Mixed analgesics; Phenacetin

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIPYRETIC ANALGESIC AGENT; CAFFEINE; CODEINE; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PHENACETIN;

ANALGESIC NEPHROPATHY; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG ABUSE; EDITORIAL; EVIDENCE BASED MEDICINE; GLOMERULUS FILTRATION RATE; HUMAN; INCIDENCE; KIDNEY TUBULE NECROSIS; LYMPHOCYTIC INFILTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; SIDE EFFECT;

ACETAMINOPHEN; ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG APPROVAL; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; KIDNEY FAILURE, CHRONIC; PHENACETIN; TERMINOLOGY;

EID: 34047150832     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl797     Document Type: Editorial

References (18)

1. Mihatsch MJ, Khanlari B, Brunner FP. Obituary to analgesic nephropathy - an autopsy study. Nephrol Dial Transplant 2006; 21: 3139-3145
2. Bluemle LW, Goldberg M. Renal accumulation of salicylate and phenacetin: possible mechanisms in the nephropathy of analgesic abuse. J Clin Invest 1968; 47: 2507-2514
3. Nanra RS, Kincaid-Smith P. Chronic effect of analgesics on the kidney. Prog Biochem Pharmacol 1972; 7: 285-323
4. Nanra RS, Stuart-Taylor J, De Leon H, White KH. Analgesic nephropathy: etiology, clinical syndrome, and clinicopathologic correlations in Australia. Kidney Int 1978; 13: 79-92
5. Henrich WL, Agodoa LE, Barrett B et al. National Kidney Foundation Position Paper. Analgesics and the kidney. Am J Kidney Dis 1996; 27: 162-165
6. De Broe ME, Elseviers MM, Bengtsson U et al. Statement. Analgesic Nephropathy. Nephrol Dial Transplant 1996; 11: 2407-2408
7. Elseviers MM, De Broe ME. Analgesic nephropathy in Belgium is related to the sales of particular analgesic mixtures. Nephrol Dial Transplant 1994; 9: 41-46
8. Noels LM, Elseviers MM, De Broe ME. Impact of legislative measures on the sales of analgesics and the subsequent prevalence of analgesic nephropathy: A comparative study in France, Sweden and Belgium. Nephrol Dial Transplant 1995; 10: 167-174
9. Elseviers MM, De Broe ME. Combination analgesic involvement in the pathogenesis of analgesic nephropathy: The european perspective. Am J Kidney Dis 1996; 28: S48-S55
10. Brunner FP, Selwood NH. End-stage renal failure due to analgesic nephropathy, its changing pattern and cardiovascular mortality. Nephrol Dial Transplant 1994; 9: 1371-1376
11. Michielsen P, De Schepper P. Trends of analgesic nephropathy in two high-endemic regions with different legislation. J Am Soc Nephrol 2001; 12: 550-556
12. Elseviers MM, Bosteels V, Cambier P et al. Diagnostic criteria of analgesic nephropathy in patients with end-stage renal failure - results of the Belgian study. Nephrol Dial Transplant 1992; 7: 479-486
13. Elseviers MM, Waller I, Nenov D et al. Evaluation of diagnostic criteria for analgesic nephropathy in patients with end-stage renal failure: results of the ANNE study. Nephrol Dial Transplant 1995; 10: 808-814
14. Henrich WL, Clark RL, Kelly JP et al. Non-contrast-enhanced computerized tomography and analgesic-related kidney disease: Report of the national analgesic nephropathy study. J Am Soc Nephrol 2006; 17: 1472-1480
15. Pommer W, De Broe ME. Analgesic nephropathy. In: Davison AM, et al. ed. Oxford Textbook of Clinical Nephrology, Oxford University Press, Oxford: 2005; 1033-1048
16. Delzell E, Shapiro S. A review of epidemiologic studies of nonnarcotic analgesics and chronic renal disease. Medicine (Baltimore) 1998; 77: 102-121
17. Feinstein AR, Heinemann LA, Curhan GC et al. Relationship between nonphenacetin combined analgesics and nephropathy: A review. Kidney Int 2000; 58: 2259-2264
18. Black D. The paradox of medical care. J R Coll Physicians Lond 1979; 13: 57-65